# CORRESP — Benitec Biopharma Inc.  (BNTC)  (CIK 0001808898)

> <strong>Benitec Biopharma Inc.  (BNTC)  (CIK 0001808898) → SEC staff</strong> · filed 2025-09-26 · ticker BNTC · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001193125-25-220122
- **Form:** CORRESP
- **Filer:** Benitec Biopharma Inc.  (BNTC)  (CIK 0001808898)
- **CIK:** 0001808898
- **Ticker:** BNTC
- **Filed:** 2025-09-26
- **SIC industry:** 2834
- **HQ:** Hayward, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1808898/000119312525220122/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1808898&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Benitec Biopharma Inc.  (BNTC)  (CIK 0001808898)

- UPLOAD — 2026-04-03 — /comment-letter/0000000000-26-003380
- CORRESP — 2026-03-20 — /comment-letter/0001193125-26-117627
- UPLOAD — 2025-09-25 — /comment-letter/0000000000-25-010472

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Benitec Biopharma Inc.  (BNTC)  (CIK 0001808898) (CIK 0001808898), filed 2025-09-26, accession 0001193125-25-220122. Retrieved via MORVS 2026-11-02 from https://api.morvs.ai/comment-letter/0001193125-25-220122.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*